Implantable medical devices for treating or preventing restenosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 21, 2005
app pub date -
Dec 10, 2004
filing date -
Jan 21, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Implantable medical devices having anti-restenotic antioxidants are disclosed. The anti-restenotic medical devices include stents and vascular grafts. Intravascular stents are preferred medical devices. The preferred anti-restenotic antioxidant is probucol. The medical devices can have coatings that include a polymer matrix. Related methods of treating or inhibiting restenosis using the Implantable medical devices are also disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully